Elucidating the genomic history of commercially used Bacillus thuringiensis subsp. tenebrionis strain NB176

Front Cell Infect Microbiol. 2023 Mar 20:13:1129177. doi: 10.3389/fcimb.2023.1129177. eCollection 2023.

Abstract

Bacillus thuringiensis subsp. tenebrionis (Btt) produces a coleopteran-specific crystal protoxin protein (Cry3Aa δ-endotoxin). After its discovery in 1982, the strain NB125 (DSM 5526) was eventually registered in 1990 to control the Colorado potato beetle (Leptinotarsa decemlineata). Gamma-irradiation of NB125 resulted in strain NB176-1 (DSM 5480) that exhibited higher cry3Aa production and became the active ingredient of the plant protection product Novodor® FC. Here, we report a comparative genome analysis of the parental strain NB125, its derivative NB176-1 and the current commercial production strain NB176. The entire genome sequences of the parental and derivative strains were deciphered by a hybrid de novo approach using short (Illumina) and long (Nanopore) read sequencing techniques. Genome assembly revealed a chromosome of 5.4 to 5.6 Mbp and six plasmids with a size range from 14.9 to 250.5 kbp for each strain. The major differences among the original NB125 and the derivative strains NB176-1 and NB176 were an additional copy of the cry3Aa gene, which translocated to another plasmid as well as a chromosomal deletion (~ 178 kbp) in NB176. The assembled genome sequences were further analyzed in silico for the presence of virulence and antimicrobial resistance (AMR) genes.

Keywords: Bacillus cereus group; Bacillus thuringiensis subsp. tenebrionis; cry3Aa; enterotoxin; nanopore; whole genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacillus thuringiensis* / genetics
  • Bacterial Proteins / genetics
  • Coleoptera* / genetics
  • Coleoptera* / metabolism
  • Endotoxins
  • Genomics
  • Hemolysin Proteins / genetics
  • Plasmids

Substances

  • Endotoxins
  • Hemolysin Proteins
  • Bacterial Proteins

Grants and funding

This study received funding from JKI Project BioSam and Biofa GmbH. Biofa GmbH was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.